{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:55:29Z","timestamp":1760244929072},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2004]]},"DOI":"10.2169\/internalmedicine.43.967","type":"journal-article","created":{"date-parts":[[2005,3,10]],"date-time":"2005-03-10T20:57:46Z","timestamp":1110488266000},"page":"967-971","source":"Crossref","is-referenced-by-count":7,"title":["High Molecular Weight Form Insulin-like Growth Factor II-producing Mesenteric Sarcoma Causing Hypoglycemia"],"prefix":"10.2169","volume":"43","author":[{"given":"Ryuji","family":"SATO","sequence":"first","affiliation":[{"name":"Division of Internal Medicine and Surgery, Tokyo Metropolitan Fuchu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyoshi","family":"TSUJINO","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Surgery, Tokyo Metropolitan Fuchu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"NISHIDA","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Surgery, Tokyo Metropolitan Fuchu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasukazu","family":"OTANI","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Surgery, Tokyo Metropolitan Fuchu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"MINAMI","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Surgery, Tokyo Metropolitan Fuchu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"SHICHIRI","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"HIZUKA","sequence":"additional","affiliation":[{"name":"Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiko","family":"AIBA","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Tokyo Women's Medical University Daini Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"HIRATA","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Marks V, Teale JD. Tumours producing hypoglycaemia. Diabetes Metab Rev 7: 79-91, 1991.","DOI":"10.1002\/dmr.5610070202"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 68: 183-223, 1996.","DOI":"10.1016\/S0065-230X(08)60354-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Daughaday WH, Trivedi B, Kapadia M. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. J Clin Endocrinol Metab 53: 289-294, 1981.","DOI":"10.1210\/jcem-53-2-289"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Daughaday WH, Kapadia M. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci USA 86: 6778-6782, 1989.","DOI":"10.1073\/pnas.86.17.6778"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. J Clin Invest 85: 1672-1679, 1990.","DOI":"10.1172\/JCI114619"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zapf J, Futo E, Peter M, Froesch ER. Can “big” insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 90: 2574-2584, 1992.","DOI":"10.1172\/JCI116152"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hizuka N, Fukuda I, Takano K, Okubo Y, Asakawa-Yasumoto K, Demura H. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia. Endocr J 45 (Suppl): S61-65, 1998.","DOI":"10.1507\/endocrj.45.Suppl_S61"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 319: 1434-1440, 1988.","DOI":"10.1056\/NEJM198812013192202"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Miyakawa M, Hizuka N, Takano K, et al. Radioimmunoassay for insulin-like growth factor I (IGF-I) using biosynthetic IGF-I. Endocrinol Jpn 33: 795-801, 1986.","DOI":"10.1507\/endocrj1954.33.795"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Asakawa K, Hizuka N, Takano K, et al. Radioimmunoassay for insulin-like growth factor II (IGF-II). Endocrinol Jpn 37: 607-614, 1990.","DOI":"10.1507\/endocrj1954.37.607"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yamaguchi M, Kamimura S, Takada J, et al. Case report :Insulin-like growth factor II expression in hepatocellular carcinoma with alcoholic liver fibrosis accompanied by hypoglycaemia. J Gastroenterol Hepatol 13: 47-51, 1998.","DOI":"10.1111\/j.1440-1746.1998.tb00544.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) D'Ercole AJ. Insulin-like growth factors and their receptors in growth. Endocrinol Metab Clin North Am 25: 573-590, 1996.","DOI":"10.1016\/S0889-8529(05)70341-8"},{"key":"13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1242\/dev.110.1.151","volume":"110","year":"1990","unstructured":"13) Lee JE, Pintar J, Efstratiadis A. Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development 110: 151-159, 1990.","journal-title":"Development","ISSN":"http:\/\/id.crossref.org\/issn\/0950-1991","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Morali OG, Jouneau A, McLaughlin KJ, Thiery JP, Larue L. IGF-II promotes mesoderm formation. Dev Biol 227: 133-145, 2000.","DOI":"10.1006\/dbio.2000.9875"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Han VK, D'Ercole AJ, Lund PK. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236: 193-197, 1987.","DOI":"10.1126\/science.3563497"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Baxter RC, Daughaday WH. Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J Clin Endocrinol Metab 73: 696-702, 1991.","DOI":"10.1210\/jcem-73-4-696"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Chung J, Henry RR. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma. J Clin Endocrinol Metab 81: 919-925, 1996.","DOI":"10.1210\/jc.81.3.919"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ron D, Powers AC, Pandian MR, Godine JE, Axelrod L. Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia. J Clin Endocrinol Metab 68: 701-706, 1989.","DOI":"10.1210\/jcem-68-4-701"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) Fehmann HC, Jehle P, Markus U, Goke B. Functional active receptors for insulin-like growth factors-I (IGF-I) and IGF-II on insulin-, glucagon-, and somatostatin-producing cells. Metabolism 45: 759-766, 1996.","DOI":"10.1016\/S0026-0495(96)90143-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Chung J, Henry RR. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma. J Clin Endocrinol Metab 81: 919-925, 1996.","DOI":"10.1210\/jc.81.3.919"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/43\/10\/43_10_967\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T19:58:43Z","timestamp":1625601523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/43\/10\/43_10_967\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.43.967","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004]]}}}